Literature DB >> 11698662

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.

H E Xu1, M H Lambert, V G Montana, K D Plunket, L B Moore, J L Collins, J A Oplinger, S A Kliewer, R T Gampe, D D McKee, J T Moore, T M Willson.   

Abstract

The peroxisome proliferator-activated receptors (PPARs) are transcriptional regulators of glucose, lipid, and cholesterol metabolism. We report the x-ray crystal structure of the ligand binding domain of PPAR alpha (NR1C1) as a complex with the agonist ligand GW409544 and a coactivator motif from the steroid receptor coactivator 1. Through comparison of the crystal structures of the ligand binding domains of the three human PPARs, we have identified molecular determinants of subtype selectivity. A single amino acid, which is tyrosine in PPAR alpha and histidine in PPAR gamma, imparts subtype selectivity for both thiazolidinedione and nonthiazolidinedione ligands. The availability of high-resolution cocrystal structures of the three PPAR subtypes will aid the design of drugs for the treatments of metabolic and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698662      PMCID: PMC61142          DOI: 10.1073/pnas.241410198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  The PPARs: from orphan receptors to drug discovery.

Authors:  T M Willson; P J Brown; D D Sternbach; B R Henke
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

Review 2.  Modifying ligand specificity of gene regulatory proteins.

Authors:  D F Doyle; D J Mangelsdorf; D R Corey
Journal:  Curr Opin Chem Biol       Date:  2000-02       Impact factor: 8.822

Review 3.  Orphan nuclear receptors: shifting endocrinology into reverse.

Authors:  S A Kliewer; J M Lehmann; T M Willson
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

4.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

5.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

6.  A single amino acid can determine the DNA binding specificity of homeodomain proteins.

Authors:  J Treisman; P Gönczy; M Vashishtha; E Harris; C Desplan
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

7.  DNA specificity of the bicoid activator protein is determined by homeodomain recognition helix residue 9.

Authors:  S D Hanes; R Brent
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

8.  DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5).

Authors:  T Czerny; M Busslinger
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

9.  Solvent-accessible surfaces of proteins and nucleic acids.

Authors:  M L Connolly
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

10.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.

Authors:  S A Kliewer; B M Forman; B Blumberg; E S Ong; U Borgmeyer; D J Mangelsdorf; K Umesono; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

View more
  119 in total

1.  Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor.

Authors:  Sabine Borngraeber; Mary-Jane Budny; Grazia Chiellini; Suzana T Cunha-Lima; Marie Togashi; Paul Webb; John D Baxter; Thomas S Scanlan; Robert J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

2.  Peroxisome proliferator-activated receptors target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.

Authors:  Bernard Pirard
Journal:  J Comput Aided Mol Des       Date:  2003-11       Impact factor: 3.686

Review 3.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

4.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

Review 5.  Structural and functional insights into nuclear receptor signaling.

Authors:  Lihua Jin; Yong Li
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

6.  Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ12,14-prostaglandin J2.

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Asoka Banno; Raju C Reddy
Journal:  ACS Chem Biol       Date:  2018-11-29       Impact factor: 5.100

7.  Molecular dynamics simulations of the human CAR ligand-binding domain: deciphering the molecular basis for constitutive activity.

Authors:  Björn Windshügel; Johanna Jyrkkärinne; Antti Poso; Paavo Honkakoski; Wolfgang Sippl
Journal:  J Mol Model       Date:  2004-12-23       Impact factor: 1.810

8.  Highly twisted adamantyl arotinoids: synthesis, antiproliferative effects and RXR transactivation profiles.

Authors:  Santiago Pérez-Rodríguez; Maria A Ortiz; Raquel Pereira; Fátima Rodríguez-Barrios; Angel R de Lera; F Javier Piedrafita
Journal:  Eur J Med Chem       Date:  2009-01-20       Impact factor: 6.514

Review 9.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

10.  Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors.

Authors:  A Bordoni; M Di Nunzio; F Danesi; P L Biagi
Journal:  Genes Nutr       Date:  2006-06       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.